Single nucleotide polymorphisms of MIR-149 gene rs2292832 contributes to the risk of hepatocellular carcinoma, but not overall cancer: A meta-analysis

Minerva Medica

Volumn 107, Issue 4, 2016, Pages 259-269

  Jia, Hongjun ^a   Yu, Hengwang ^b   Liu, Qingzhan ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b People's Hospital of Linshu   (China)

Author keywords

Human; MIRN149 micro RNA; Neoplasms; Polymorphism; Single nucleotide

Indexed keywords

MICRORNA; MICRORNA 149; UNCLASSIFIED DRUG; MIRN149 MICRORNA, HUMAN;

CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; CARCINOMA, HEPATOCELLULAR; GENETICS; LIVER NEOPLASMS; META ANALYSIS; NEOPLASMS; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84978864116     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal. Cancer Statistics, 2015. CA Cancer J Clin 2015; 65:5-29.
2. Liu Y, Pan S, Liu L., Zhai X, Liu J, Wen J., et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7:e35145.
3. El-Serag H.B., Rudolph KL Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-76.
4. Kim WH, Min KT, Jeon Y.J., Kwon CI, Ko KH, Park PW, et al Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012; 504:92-7.
5. Wang J, Wang Q, Liu H., Shao N, Tan B, Zhang G., et al. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a metaanalysis of 32 studies. Mutagenesis 2012; 27:779-88.
6. Ryan BM, Robles AI, Harris CC Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10:389-402.
7. Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol 2009; 578:3-22.
8. Hu Z, Chen J, Tian T., Zhou X, Gu H, Xu L., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118:2600-8.
9. Hu Z, Liang J, Wang Z., Tian T, Zhou X, Chen J., et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30:79-84.
10. Slaby O, Bienertova-Vasku J, Svoboda M., Vyzula R. Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 2012; 16:8-21.
11. Landau DA, Slack FJ MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol 2011; 38:743-51.
12. Zeng Y, Cullen BR Sequence requirements for micro RNA processing and function in human cells. RNA 2003; 9:112-23.
13. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 2004; 208:1-33.
14. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16:1124-31.
15. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995; 142:371-82.
16. Higgins JP, Thompson SG, Deeks J.J., Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-60.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-48.
19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-101.
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
21. Tian T, Shu Y, Chen J., Hu Z, Xu L, Jin G. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:1183-7.
22. Liu Z, Li G, Wei S., Niu J, El-Naggar AK, Sturgis EM, et al Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010; 116:4753-60.
23. Vinci S, Gelmini S, Pratesi N., Conti S, Malentacchi F, Simi L., et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 2011; 49:2073-80.
24. Ahn DH, Rah H, Choi Y.K., Jeon YJ, Min KT, Kwack K, et al Association of the miR-146aOG, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog 2013; 52 Suppl 1:E39-51.
25. Zhang MW, Jin MJ, Yu Y.X., Zhang SC, Liu B, Jiang X, et al Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk. Mol Carcinog 2012; 51 Suppl 1:E21-31.
26. Min KT, Kim JW, Jeon Y.J., Jang MJ, Chong SY, Oh D, et al Association of the miR-146aOG, 1490T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog 2012; 51 Suppl LE65-73.
27. Zhang M1, Jin M, Yu Y, Zhang S, Wu Y, Liu H, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl) 2012; 21:274-80.
28. Kim WH, Min KT, Jeon Y.J., Kwon CI, Ko KH, et al. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012; 504:92-7.
29. Chu YH, Tzeng SL, Lin C.W., Chien MH, Chen MK, Yang SF. Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer. PLoS One 2012; 7:e39777.
30. Vinci S, Gelmini S, Mancini I., Malentacchi F, Pazzagli M, Beltrami C., et al. Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods 2013; 59:138-46.
31. Lv M, Dong W, Li L., Zhang L, Su X, Wang L., et al. Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population. J Cancer Res Clin Oncol 2013; 139:1405-10.
32. Huang GL, Lu Y, Pu X.X., He YX, Chen ML, Li YZ, et al Association study between miR-149 gene polymorphism and nasopharyngeal carcinoma. Biomed Rep 2013; 1:599-603.
33. Dikeakos P, Theodoropoulos G, Rizos S., Tzanakis N, Zografos G, Gazouli M. Association of the miR-146aC > G, miR-149T > C, and miR-196a2T >C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep 2014; 41:1075-80.
34. Wu R. The Association of miR-SNP with the Susceptibility of Colorectal Cancer and Response to Chemotherapy, Soochow University, Suzhou, China, 2014.
35. Wei WJ, Lu ZW, Li D.S., Wang Y., Zhu YX, Wang ZY, et al. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinico-pathologic characteristics in a Chinese population. Int J Mol Sci 2014; 15:20968-81.
36. Wang XH, Wang FR, Tang Y.F., Zou HZ, Zhao YQ. Association of miR-149C > T and miR-499A > G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population. Genet Mol Res 2014; 13:5048-54.
37. Liu MF, Chen WQ, He Y.Z., Gu YL. Role of miR-149 C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population. Genet Mol Res 2014; 13:7184-9.
38. Pratedrat P, Sopipong W, Makkoch J., Praianantathavorn K, Chuaypen N, Tangkijvanich P., et al. Single Nucleotide Polymorphisms in miR-149 (rs2292832) and miR-101-1 (rs7536540) Are Not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection. Asian Pac J Cancer Prev 2015; 16:6457-61.
39. Kloosterman WP, Plasterk RH The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11:441-50.
40. Lagos-Quintana M., Rauhut R, Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294:853-8. '
41. Ambros V MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113:673-6.
42. Lu J, Getz G, Miska E.A., Alvarez-Saavedra E, Lamb J, Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8.
43. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28:2-12.
44. Stefani G, Slack FJ Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008; 9:219-30.
45. Garzon R, Calin GA, Croce CM MicroRNAs in Cancer. Annu Rev Med 2009; 60:167-79.
46. Zou P, Zhao L, Xu H., Chen P, Gu A, Liu N., et al. Hsamir-499 rs3746444 polymorphism and cancer risk: a meta-analysis. J Biomed Res 2012; 26:253-9.